Abstract
Although the pharmacology of opiates will be comprehensively reviewed in this chapter, a major emphasis and depth of the discussion will concern the psychopharmacological effects of opiates. Under this rubric the subjectively perceived effects, objective behavioral observations, and correlative influence of physiological function will be emphasized. Underlying mechanisms of action will be discussed if applicable. The reader, however, is referred to Chapter 2 for a thorough discussion of chemical structure-activity relationships. Reference will be made to this area when relevant to the discussion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adler, R., and Lomazzi, F., 1973, Perceptual style and pain tolerance. I. The influence of certain psychological factors, J. Psychosom. Res. 17:369–379.
Altman, J., and Mansky, P. A., 1977, A conceptual model of drug dependence, in: Renewal in Psychiatry: A Critical Rational Perspective (T. C. Manschreck and A. M. Kleinman, eds.), pp. 139–161, Hemisphere Publishing Corp., Washington, D.C.
Andrews, H. L., and Himmelsbach, C. K., 1944, Relationship of the intensity of the morphine abstinence syndrome to dosage, J. Pharmacol. Exp. Ther. 81:288–293.
Axelrod, J., 1956a, Possible mechanisms of tolerance to narcotic drugs, Science 124:263–264.
Axelrod, J., 1956b, The enzymatic N-demethylation of narcotic drugs, J. Pharmacol. 117:322–350.
Axelrod, J., 1968, Cellular adaptation in the development of tolerance to drugs, in: The Addictive States (A. Wikler, ed.), pp. 247–262, Williams & Wilkins, Baltimore.
Barber, T. X., 1959, Toward a theory of pain: Relief of chronic pain by prefrontal leucotomy, opiates, placebos, and hypnosis, Psychol. Bull. 56:430–460.
Batterman, R. C, 1943, Clinical effectiveness and safety of a new synthetic analgesic drug, demerol, Arch. Int. Med. 71:345–356.
Beaver, W. T., Wallenstein, S. L., Houde, R. W., Rogers, A., 1966, A comparison of the analgesic effects of pentazocine and morphine in patients with cancer, Clin. Pharmacol. Ther. 7:740–751.
Beaver, W. T., Wallenstein, S. L., Houde, R. W., and Rogers, A., 1967, A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone, Clin. Pharmacol. Ther. 8:415–426.
Beckett, A. H., Casy, A. F., and Harper, N. J., 1956, Analgesics and their antagonists: Some steric and chemical considerations. Part III. The influence of the basic group on biological response, J. Pharm. Pharmacol. 8:874–883.
Beecher, H. K., 1946, Pain in men wounded in battle, Ann. Surg. 123:96–103.
Beecher, H. K., 1955, The powerful placebo, JAMA 159:1602–1606.
Beecher, H. K., 1956a, The subjective response and reaction to sensation, Am. J. Med. 20:107–113.
Beecher, H. K., 1956b, Relationship of significance of wound to pain experienced, JA MA 161:1609–1613.
Beecher, H. K., 1957, The measurement of pain, Pharmacol. Rev. 9:59–209.
Beecher, H. K., 1959a, Measurement of Subjective Responses, Oxford Univ. Press, New York.
Beecher, H. K., 1959b, Generalizations from pain of various types and diverse origins, Science 130:267–268.
Beecher, H. K., 1960, Increased stress and effectiveness of placebos and “active” drugs, Science 132:91–92.
Beecher, H. K., 1966, Pain: One mystery solved, Science 151:840–841.
Bellville, J. W., Forrest, W. H., and Brown, B. W., 1968a, Clinical and statistical methodology for cooperative clinical assays of analgesics, Clin. Pharmacol. Ther. 9:290–302.
Bellville, J. W., Forrest, W. H., Elashoff, J., and Laska, E., 1968b, Evaluating side effects of analgesics in a cooperative clinical study, Clin. Pharmacol. Ther. 9:303–313.
Bellville, J. W., Forrest, W. H., Shroff, P., and Brown, B. W., 1971, The hypnotic effects of codeine and secobarbital and their interactions in man, Clin. Pharmacol. Ther. 12:607–612.
Berger, H., 1931, Über das Eliktrencephalogram des Menschen, Arch. Psychiat. Nervenkr. 94:16–60.
Bergh, G. S., and Layne, J. A., 1940, A demonstration of the independent contraction of the sphincter of the common bile duct in human subjects, Am. J. Physiol. 128:690–694.
Berlin, L, Guthrie, T., Goodell, H., and Wolff, H. G., 1952, Analysis of the reflex function of the isolated human spinal cord using measured stimuli, Trans. Am. Neurol. Assoc. 77:106–110.
Bickerman, H. A., 1962, Clinical pharmacology of antitussive agents, Clin. Pharmacol. Ther. 3:353–367.
Bloom, W. A., and Butcher, B. T., 1970, Methadone side effects and related symptoms in 200 methadone maintenance patients, Proceedings Third National Conference on Methadone Treatment, pp. 44-49.
Bogoch, A., Roth, J. L. A., and Bockus, H. L., 1954, The effects of morphine on serum amylase and lipase, Gastroenterology 26:697–708.
Bowsher, D., 1957, Termination of the central pain pathway in man: The conscious appreciation of pain, Brain 80:606–622.
Brotman, R. F., Meyer, A. S., and Freedman, A. M., 1965, An approach to treating narcotic addicts based on a community mental health diagnosis, Comp. Psychiatry 6:104.
Burroughs, W. S., 1959, Naked Lunch, Castle Books by arrangement with Grove Press, New York.
BuTsch, W. L., McGowAn, J. M., and Walters, W., 1936, Clinical studies on the influence of certain drugs in relation to biliary pain and to variations in intrabiliary pressure, Surg. Gynecol. Obstet. 63:451–456.
Caroli, J., Porcher, P., Pequignot, G., and Dalattre, M., 1960, Contribution of cineradiography to study of the function of the human biliary tract. Am. J. Dig. Dis. 5:677–696.
Carruyo, L., Florio, V., Longo, V. G., scotti De Carolis, A., 1968, The effect of narcotics and narcotic antagonists on the electrical activity of the brain: Its relationship with their pain-obtunding activity, in: Pain (A. Soulairac, J. Cahn, and J. Charpentier, eds.), pp. 425–439, Academic Press, London/New York.
Cautela, J., 1967, Covert sensitization, Psychol. Rep. 20:459–468.
Cautela, J., 1970, Covert reinforcement, Behav. Ther. 1:33–50.
Cautela, J., 1971, Covert extinction, Behav. Ther. 2:192–200.
Chakravarty, N. K., Matallana, A., Jensen, R., and Borison, H. L., 1956, Central effects of antitussive drugs on cough and respiration, J. Pharmacol. Exp. Ther. 117:127–135.
Chapman, C. R., and Feather, B. W., 1973, Effects of diazepam on human pain tolerance and pain sensitivity, Psychosom. Med. 35:330–340.
Chapman, C. R., Murphy, T. M., and Butler, S. H., 1973, Analgesic strength of 33 per cent nitrous oxide: A signal detection theory evaluation, Science 179:1246–1248.
Charpentier, J., 1968, Analysis and measurement of pain in animals, a new conception of pain, in: Pain (A. Soulairac, J. Cahn, and J. Charpentier, eds.), pp. 171–200, Academic Press, London/New York.
Cherubin, C. F., 1967. The medical sequelae of narcotic addiction, Ann. Int. Med. 67:23–33.
Clark, W. C., 1969, Sensory decision theory analysis of the placebo effect on the criterion for pain and thermal sensitivity (d′), J. Abnorm. Psychol. 74:363–371.
Clark, W. F. Le Gros, 1932, The structure and connections of the thalamus, Brain 55:406–470.
Cochin, J., and Kornetsky, C., 1968, Factors in blood of morphine-tolerant animals that attenuate or enhance effects of morphine in nontolerant animals, in: The Addictive States (A. Wikler, ed.), pp. 268–277, Williams & Wilkins, Baltimore.
Collier, H. O. J., 1966, Tolerance, physical dependence, and receptors, in: Advances in Drug Research, Vol. 3 (N. J. Harper and A. B. Simmonds, eds.), pp. 171–188, Academic Press, New York.
Comroe, J. H., and Dripps, R. D., 1948, Reactions to morphine in ambulatory and bed patients, Surg. Gynecol. Obstet. 87:221–227.
Daniel, E. E., Sutherland, W. H., and Bogoch, A., 1959, Effects of morphine and other drugs on the motility of the terminal ileum, Gastroenterology 36:510–523.
Dole, V. P., 1970, Biochemistry of addiction, Annu. Rev. Biochem. 39:821–840.
Dorcus, R. M., and Kirkner, F. J., 1948, The use of hypnosis in the suppression of intractable pain, J. Abnorm. Soc. Psychol. 43:237–239.
Drew, J. H., Dripps, R. D., and Comroe, J. H., 1946, Clinical studies on morphine. III. The effect of morphine upon the circulation of man and upon the circulatory and respiratory responses to tilting, Anesthesiology 7:44–61.
Dripps, R. D., and Comroe, J. H., 1945, Clinical studies on morphine. I. The immediate effect of morphine administered intravenously and intramuscularly upon respiration in normal man, Anesthesiology 6:462–468.
Eckenhoff, J. E., and Oech, S. R., 1960, The effects of narcotics and antagonists upon respiration and circulation in man, Clin. Pharmacol. Ther. 1:483–524.
Eckenhoff, J. E., Helrich, M., and Hege, M. J. D., 1956, A method for studying respiratory functions in awake or anesthetized patients, Anesthesiology 17:66–72.
Eddy, N. B., Halbach, H., and Braeden, O. J., 1957, Synthetic substances with morphinelike effect, clinical experience: Potency, side-effects, addiction liability, Bull. WHO 17:569–863.
Ehrenpreis, S., Greenberg, J., and Comaty, J. E., 1975, Mechanism of development of tolerance to injected morphine by guinea pig ileum, Life Sci. 17:49–54.
Eisenman, A. J., Sloan, J. W., Martin, W. R., Jasinski, D. R., and Brooks, J. W., 1969, Catecholamine and 17-hydroxycorticosteroid excretion during a cycle of morphine dependence in man, J. Psychiat. Res. 7:19–28.
Elliot, H. W., Tolbert, B. M., Adler, T. K., and Anderson, H. H., 1954, Excretion of carbon-14 by man after administration of morphine-n-methyl-C14, Proc. Soc. Exp. Biol. Med. 85:77–81.
Elliot, H. W., Navarro, G., Nomof, N., 1970, A double blind controlled study of the pharmacologic effects of nalbuphine (EN-2234A), J. Med. 1:74–89.
Elliot, H. W., Parker, K. D., Wright, J. A., and Nomof, N., 1971, Actions and metabolism of heroin administered by continuous intravenous infusion to man, Clin. Pharmacol. Ther. 12:806–814.
Evans, W. G., 1962, The synergism of autonomic drugs on opiate or opioid-induced analgesia. A discussion of its potential utility, Mil. Med. 127:1000–1003.
Fabrega, H., Jr., and Van Egeren, L., 1976, A behavioral framework for the study of human disease, Ann. Int. Med. 84:200–208.
Feather, B. W., Chapman, C. R., and Fisher, S. B., 1972, The effect of a placebo on the perception of painful radiant heat stimuli, Psychosom. Med. 34:290–294.
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G., and Munoz, R., 1972, Diagnostic criteria for use in psychiatric research, Arch. Gen. Psychiat. 26:57–63.
Feldstein, S., Chesler, P., and Fink, M., 1973, Psychological differentiation and the response of opiate addicts to pharmacological treatment, Br. J. Addict. 68:151–157.
Fisher, C. M., 1967, Some neuro-ophthalmological observations, J. Neurol. Neurosurg. Psychiat. 30:383–392.
Fisher, C. M., 1969, The neurological examination of the comatose patient, Acta. Neurol. Scand. 45, Suppl. 36:1–56.
Foldes, F. F., 1974, The role of drugs in the management of intractable pain, in: Relief of Intractable Pain (M. Swerdlow, ed.), Excerpta Medica, New York.
Fordyce, W. E., 1974a, Pain viewed as learned behavior, in: Advances in Neurology, Vol. 4, International Symposium on Pain (J. J. Bonica, ed.), pp. 415–422, Raven Press, New York.
Fordyce, W. E., 1974b, Treating chronic pain by contingency management, in: Advances in Neurology, Vol. 4, International Symposium on Pain (J. J. Bonica, ed.), pp. 415–422, Raven Press, New York.
Forrest, W. H., Beer, E. G., Bellville, W. J., Ciliberti, B. J., and Paddock, R., 1969, Analgesic and other effects of the d- and l-isomers of pentazocine, Clin. Pharmacol. Ther. 10:468–476.
Forrest, W. R, Jr., Bellville, J. W., Beer, W. G., and Brown, B. W., Jr., 1970, Interaction of morphine and dextroamphetamine for the treatment of postoperative pain in man, Pharmacologist 12:2(Abst.).
Fraser, H. F., 1968, Methods for assessing the addiction liability of opioids and opioid antagonists in man, in: The Addictive States (A. Wikler, ed.), pp. 176–187, Williams & Wilkins, Baltimore, Maryland.
Fraser, H. F., and Isbell, H., 1952, Comparative effects of 20 mg. of morphine sulfate in non-addicts and former morphine addicts, J. Pharmacol. Exp. Ther. 105:498–502.
Fraser, H. F., and Isbell, H., 1960, Human pharmacology and addiction liabilities of phenazocine and levophenacylmorphan, Bull. Narc. 12:15–23.
Fraser, H. F., and Isbell, H., 1961, Human pharmacology and addictiveness of ethyl l-(-3-cyano-3,3-phenylpropyl)-4-phenyl-4-piperidine carboxylalate hydrochloride (R-1132, diphenoxylate), Bull. Narc. 13:29–43.
Fraser, H. F., Nash, T. L., Van Horn, G. D., and Isbell, H., 1954, Use of miotic effect in evaluating analgesic drugs in man, Arch. Int. Pharmacodyn. 98:443–451.
Fraser, H. F., Isbell, H., and Van Horn, G. D., 1958a, Norcodeine in man, Fed. Proc. 17, No. 1449.
Fraser, H. F., Wikler, A., Van Horn, G. D., Eisenman, A. J., and Isbell, H., 1958b. Human pharmacology and addiction liability of morphine, J. Pharmacol. Exp. Ther. 122:359–369.
Fraser, H. F., Van Horn, G. D., Martin, W. R., Wolback, A. B., Isbell, H., 1961, Methods for evaluating addiction liability, (a) “Attitude” of opiate addicts toward opiate-like drugs, (b) A short-term “direct” addiction test, J. Pharmacol. Exp. Ther. 133:371–387.
Fraser, H. F., Jones, B. E., Rosenberg, D. E., and Thompson, A. K., 1963, Effects of addiction to intravenous heroin on patterns of physical activity in man, Clin. Pharmacol. Ther. 4:188–196.
Freedman, A. M., Fink, M., Sharoff, R., and Zaks, A., 1967, Cyclazocine and methadone in narcotic addiction, JAMA 202:191–194.
Freedman, A. M., Fink, M., Sharoff, R., and Zaks, A., 1968, Clinical studies of cyclazocine in the treatment of narcotic addiction, Am. J. Psychiat. 124:1499–1504.
Geoghegan, J. J., 1946, Manic depressive psychosis (manic phase) and electroshock, Canad. Med. Assn. J. 55:54.
Gibbs, F. A., and Maltby, G. L., 1943, Effect on electrical activity of the cortex of certain depressant and stimulant drugs—barbiturates, morphine, caffeine, benzedrine and adrenalin, J. Pharmacol. Exp. Ther. 78:1–10.
Gilbert, P. E., and Martin, W. R., 1975, Antagonism of the convulsant effects of heroin, d-propoxyphene, meperidine, normeperidine, and thebaine by naloxone in mice, J. Pharmacol. Exp. Ther. 192:538–541.
gilghrist, J. C, and Nesberg, L. S., 1952, Need and perceptual change in need-related objects, J. Exp. Psychol. 44:369–376.
Goldiamond, I., 1958, Indicators of perception: I. Subliminal perception, subception, unconscious perception: An analysis in terms of psychophysical indicator methodology, Psychol. Bull. 55:373–411.
Goldstein, A., and Goldstein, D. B., 1968, Enzyme expansion theory of drug tolerance and physical dependence, in: The Addictive States (A. Wikler, ed.), pp. 265–267, Williams & Wilkins, Baltimore.
Gorodetzky, C. W., 1973, Time course of morphine (M) detection in human urine after IV morphine, Fed. Proc. 32:764.
Gorodetzky, C. W., 1975, Time course of morphine (M) detection in human urine after IV heroin (H) by EMIT and RIA-I125, Fed, Proc. 3:814.
Gorodetzky, C. W., and Martin, W. R., 1965, A comparison of fentanyl, droperidol, and morphine, Clin. Pharmacol. Ther. 6:731–739.
Gorodetzky, C. W., Angel, C. R., Beach, D. J., Catlin, D. H., and Yeh, S. Y., 1974. Validity of screening methods for drugs of abuse in biological fluids. I. Heroin in urine, Clin. Pharmacol. Ther. 15:461–472.
Granacher, R. P., and Baldessarini, R. J., 1975, Phystostigmine, Arch. Gen. Psychiat. 32:375–380.
Gravenstein, J. S., Smith, G. M., Sphire, R. D., Isaacs, J. P., and Beecher, H. K., 1956, Dihydrocodeine, further development in measurement of analgesic power and appraisal of psychologic side effects of analgesic agents, N. Engl. J. Med. 254:877–885.
Greenhoot, J. H., and Sternbach, R. A., 1974, Conjoint treatment of chronic pain, in: Advances in Neurology, Vol. 4, International Symposium on Pain (J. J. Bonica, ed.), Raven Press, New York.
Grendahl, H., and Hansteen, V., 1969, The effect of morphine on blood pressure and cardiac output in patients with acute myocardial infarction, Acta Med. Scand. 186:515–517.
Guttner, L. B., Gould, W. J., and Batterman, R. C., 1952, The effects of potent analgesics upon vestibular function, J. Clin. Invest. 31:259–266.
Gyang, E. A., and Kosterlitz, H. W., 1966, Agonist and antagonist actions of morphinelike drugs on the guinea-pig isolated ileum. Br. J. Pharmacol. Chemother. 27:514–527.
Hackett, T. P., 1971, Pain and prejudice, Med. Times 99:130–138.
Hackett, T. P., White, J. C., and Sweet, W. H., 1966, Leukotomy for the relief of pain: The selection of cases and psychological hazards, in: Pain (R. S. Knighton and P. R. Dumke, eds.), Little, Brown, Boston.
Haertzen, C. A., 1966, Development of scales based on patterns of drug effects, using the addiction research center inventory (ARCI), Psychol. Rep. 18:163–194.
Haertzen, C. A., 1970, Subjective effects of narcotic antagonists cyclazocine and nalorphine on the addiction research center inventory (ARCI), Psychopharmacologia 18:366–377.
Haertzen, C. A., 1974, Subjective effects of narcotic antagonists, in: Narcotic Antagonists (M. C. Braude, L. S. Harris, E. L. May, J. P. Smith, and J. E. Villarreal, eds.), pp. 383–398, Raven Press, New York.
Haertzen, C A., and Hooks, N. T., 1969, Changes in personality and subjective experience associated with the chronic administration and withdrawal of opiates, J. Nerv. Ment. Dis. 148:606–614.
Haertzen, C. A., Hill, H. E., and Bellville, J. W., 1963, Development of the addiction research center inventory (ARCI): Selection of items that are sensitive to the effects of various drugs, Psychopharmacologia 4:155–166.
Hebb, D. O., 1955, Drives and the cns (conceptual nervous system), Psychol. Rev. 62:243–254.
Herold, M., and Cahn, J., 1968, The possible role of serotonin in pain, in: Pain (A. Soulairac, J. Cahn, and J. Charpentier, eds.), pp. 251–280, Academic Press, London/ New York.
Herrnstein, R. J., 1962, Placebo effect in the rat, Science 138:677–678.
Herz, A., Albus, K., Metys, J., Schubert, P., and Teschemacher, H. J., 1970, On the central sites for the antinociceptive action of morphine and fentanyl, Neuropharmacology 9:539–551.
Hewer, A. J. H., and Keele, C A., 1948, A method of testing analgesics in man, Lancet ii:683–688.
Hewer, A. J. H., Keele, C. A., Keele, K. D., and Nathan, P. W., 1949, A clinical method of assessing analgesics, Lancet i:431–435.
Hill, H. E., Kornetsky, C. H., Flanary, H. G., and Wikler, A., 1952a, Effects of anxiety and morphine on discrimination of intensities of painful stimuli, J. Clin. Invest. 3:473–480.
Hill, H. E., Kornetsky, C. H., Flanary, H. G., and Wikler, A., 1952b, Studies on anxiety associated with anticipation of pain, I. Effects of morphine, Arch. Neurol. Psychiat. 67:612–619.
Hill, H. E., Bellville, R. E., and Wikler, A., 1955, Studies on anxiety associated with anticipation of pain. II. Comparative effects of pentobarbitol and morphine, Arch. Neurol. Psychiat. 73:602–608.
Hill, H. E., Belleville, R. E., and Wikler, A., 1957, Motivational determinants in modification of behavior by morphine and pentobarbital, A.M.A. Arch. Neurol. Psychiat. 77:28–35.
Hill, H. E., Haertzen, C. A., and Glaser, R., 1960, Personality characteristics of narcotic addicts as indicated by the MMPI, J. Gen. Psychol 62:127–139.
Hill, H. E., Haertzen, C. A., Wolback, A. B., and Miner, E. J., 1963a, The addiction research center inventory: Standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbitol, alcohol, LSD-25, pyrahexyl and chlorpromazine, Psychopharmacologia 4:167–183.
Hill, H. E., Haertzen, C. A., Wolback, A. B., and Miner, E. J., 1963b, The addiction research center inventory: Appendix, Psychopharmacologia 4:184–205.
Himmelsbach, C. K., 1941a, The morphine abstinence syndrome, its nature and treatment, Ann. Int. Med, 15:829–839.
Himmelsbach, C. K., 1941b, Studies on the relation of drug addiction to the autonomic nervous system: Result of cold pressor tests, J. Pharmacol. Exp. Ther. 73:91–98.
Himmelsbach, C. K., 1942, Clinical studies of drug addiction, physical dependence, withdrawal and recovery, Arch. Int. Med. 69:766–772.
Hoffmeister, F., 1968, Effects of psychotropic drugs on pain, in: Pain (A. Soulairac, J. Cahn, and J. Charpentier, eds.), pp. 309–319, Academic Press, London/New York.
Hopton, D. S., and Torrance, H. B., 1967, Action of various new analgesic drugs on the human common bile duct, Gut 8:296–300.
Houde, R. W., 1974, The use and misuse of narcotics in the treatment of chronic pain, in: Advances in Neurology, Vol. 4, International Symposium on Pain (J. J. Bonica, ed.), pp. 527–536, Raven Press, New York.
Houde, R. W., Wallenstein, S. L., and Rogers, A., 1960, Clinical pharmacology of analgesics: 1. A method of assaying analgesic effect, Clin. Pharmacol. Ther. 1:163–174.
Houde, R. W., Wallenstein, S. L., and Beaver, W. T., 1965, Clinical measurement of pain, in: Analgetics (G. de Stevens, ed.), pp. 75–122, Academic Press, New York/London.
Huggins, R. A., and Moyer, J. H., 1955, Some effects of n-allylnormorphine on normal subjects in a review of the literature, Anesthesiology 16:82–90.
Iggo, A., 1972, Critical remarks on the gate control theory, in: Pain (R. Jansen, W. D. Keidel, A. Herz, and C. Steichele, eds.) (English Ed., J. P. Payne, and R. A. P. Burt, eds.), pp. 127–128, Williams & Wilkins, Baltimore.
Isbell, H., 1948, The newer analgesic drugs; their use and abuse, Ann. Int. Med, 29:1003–1013.
Isbell, H., 1956, Attempted addiction to nalorphine, Fed, Proc. 15:442.
Isbell, H., and Chruściel, T. L., 1970, Dependence liability of “nonnarcotic” drugs. Bull. WHO 43 (Suppl.): 1–111.
Isbell, H., and White, W. M., 1953, Clinical characteristics of addictions, Am. J. Med, 14:558–565.
Jaffe, J. H., and Sharpless, S. K., 1965, The rapid development of physical dependence on barbiturates, J. Pharmacol. Exp. Ther. 150:140–145.
Jasinski, D. R., and Mansky, P. A., 1972, Evaluation of nalbuphine for abuse potential, Clin. Pharmacol. Ther. 13:78–90.
Jasinski, D. R., and Martin, W. R., 1967, Evaluation of a new photographic method for assessing pupil diameters, Clin. Pharmacol. Ther. 8:271–272.
Jasinski, D. R., and Nutt, J. G., 1973, Progress report on the clinical assessment program at the addiction research center. Report of the thirty-fifth annual scientific meeting, Committee on Problems of Drug Dependence, NAS-NRC, p. 108-130.
Jasinski, D. R., Martin, W. R., and Haertzen, C. A., 1967, The human pharmacology and abuse potential of n-allylnoroxymorphine (naloxone), J. Pharmacol. Exp. Ther. 157:420–426.
Jasinski, D. R., Martin, W. R., and Sapira, J. D., 1968, Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone, Clin. Pharmacol. Ther. 9:215–222.
Jasinski, D. R., Martin, W. R., and Hoeldtke, R. D., 1970, Effects of short-and long-term administration of pentazocine in man, Clin. Pharmacol. Ther. 11:385–403.
Jasinski, D. R., Martin, W. R., and Hoeldtke, R., 1971, Studies of the dependence producing properties of GPA-1657, profadol, and propiram in man, Clin. Pharmacol. Ther. 12:613–649.
Jones, M. H., 1956, Second pain: Fact or artifact, Science 124:442–443.
Kay, D. C., 1973, Sleep and some psychoactive drugs, Psychosomatics 14:108–118.
Kay, D. C., 1975, Human sleep and EEG through a cycle of methadone dependence. Electroencephalogr. Clin. Neurophysiol. 38:35–43.
Kay, D. C., Gorodetsky, C. W., and Martin, W. R., 1967, Comparative effects of codeine and morphine in man, J. Pharmacol. Exp. Ther. 156:101–106.
Kay, D. C., Eisenstein, R. B., Jasinski, D. R., 1969, Morphine effects on human REM state, waking state and NREM sleep, Psychopharmacologia (Berlin) 14:404–416.
Keats, A. S., and Beecher, H. K., 1950, Pain relief with hypnotic doses of barbiturates and a hypothesis, J. Pharmacol. 100:1–13.
Keats, A. S., and Beecher, H. K., 1952, Analgesic potency and side action liability in man of heptazone, win 1161-2, 6-methyl dihydromorphine, metopan, levo-isomethadone and pentobarbital sodium as a further effort to refine methods of evaluation of analgesic drugs, J. Pharmacol. 105:109–129.
Keats, A. S., and Telford, J., 1957, Subjective effects of nalorphine in hospitalized patients, J. Pharmacol. Exp. Ther. 119:370–375.
Keats, A. S., and Telford, J., 1964, Studies of analgesic drugs. VIII. A narcotic antagonist analgesic without pyschotomimetic effects, J. Pharmacol. Exp. Ther. 143:157–164.
Keats, A. S., and Telford, J., 1968, Annual report, continuing study of narcotic antagonists as analgesics. Report of thirtieth scientific meeting of the Committee of Problems of Drug Dependence, NAS-NRC, pp. 5514-5530.
Keats, A. S., Beecher, H. K., and Mosteller, F. C., 1950, Measurement of pathological pain in distribution to experimental pain, J. Appl. Physiol. 3:35–44.
Keele, C. A., and Armstrong, D., 1964, Substances Producing Pain and Itch, Williams & Wilkins, Baltimore.
Kerr, F. W. L., 1975, Pain, a central inhibitory balance theory, Mayo Clin. Proc. 50:685–690.
Kerr, F., and Donald, K. W., 1974, Analgesia in myocardial infarction, Br. Heart J. 36:117–121.
Kilcoyne, M. M., Daly, J. J., Gocke, D. J., Thomson, G. E., Meltzer, J., Hsu, K. C, and Tannenbaum, M., 1972, Nephrotic syndrome in heroin addicts, Lancet i: 17–20.
Kolb, L., 1925, Pleasure and deterioration from narcotic addiction, Ment. Hyg. 9:699–724.
Kornetsky, C, 1954, Effects of anxiety and morphine on the anticipation and perception of painful thermal stimuli, J. Comp. Physiol. Psychol. 47:130–132.
Kosterlitz, H. W., Waterfield, A. A., and Berthoud, V., 1974, Assessment of the agonist and antagonist properties of narcotic analgesic drugs by their actions on the morphine receptor in the guinea pig ileum, in: Narcotic Antagonists (Advances in Biochemical Psychopharmacology) (M. C. Braude, L. S. Harris, E. L. May, J. P. Smith, and J. E. Villarreal, eds.), Raven Press, New York.
Laidlow, J., Read, A. E., and Sherlock, S., 1961, Morphine tolerance in hepatic cirrhosis, Gastroenterology 40:389–396.
Lasagna, L., 1964, The clinical evaluation of morphine and its substitutes as analgesics, Pharmacol. Rev. 16:47–83.
Lasagna, L., 1965, Drug interaction in the field of analgesic drugs, Proc. Roy. Soc. Med. 58:978–983.
Lasagna, L., and Beecher, H. K., 1954a, The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J. Pharmacol. Exp. Ther. 112:356–363.
Lasagna, L., and Beecher, H. K., 1954b, The analgesic effectiveness of codeine and meperidine (demerol), J. Pharmacol. Exp. Ther. 112:306–311.
Lasagna, L., Mosteller, F., Von Felsinger, J. M., and Beecher, H. K., 1954, A study of the placebo response, Am. J. Med. 16:770–779.
Lasagna, L., Von Felsinger, J. M., and Beecher, H. K., 1955, Drug induced mood changes in man, I. Observations of healthy subjects, chronically ill patients and “post addicts,” JAMA 157:1006–1020.
Lee, L. E., 1942, Studies of morphine, codeine and their derivatives. XVI. Clinical studies of morphine, methyldihydromorphinone (metopan) and dihydrodesoxymorphine-d (desmorphine), J. Pharmacol. Exp. Ther. 75:161–173.
Levi, A. J., 1965, Some aspects of drug metabolism in liver disease, in: Therapeutic Agents and the Liver (N. Mclntyre, and S. Sherlock, eds.), F. A. Davis, Philadelphia.
Lewis, S. A., Oswald, I., Evans, J. I., Akindele, M. O., and Tompset, S. L., 1970, Heroin and human sleep, Electroencephalogr. Clin. Neurophysiol. 28:374–381.
Libet, B., 1957, Delayed pain as a peripheral sensory pathway, Science 126:256–258.
Lim, R. K. S., and Guzman, F., 1968, Manifestations of pain in analgesic evaluation in animals and man, in: Pain (A. Soulairac, J. Cahn, and J. Charpentier, eds.), pp. 119–152, Academic Press, London/New York.
Lindesmith, A. R., 1947, Opiate Addiction, Principia Press, Bloomington, Indiana.
Lindvall, O., Björklund, A., Nobin, A., and Stenevi, U., 1974, The adrenergic innervation of the rat thalamus as revealed by glyoxylic acid flourescence method, J. Comp. Neurol. 154:317–348.
Lowenstein, E., Hallowell, P., Levine, F. H., Daggett, W. M., Austen, W. G., and Laver, M. B., 1969, Cardiovascular response to large doses of intravenous morphine in man, N. Engl. J. Med, 281:1389–1393.
Luria, R. A., 1973, The Working Brain (Trans, by B. Haigh), Basic Books, New York.
Maher, B. A., 1966, Principles of Psychopathology, an Experimental Approach, McGraw-Hill, New York.
Malmo, R. B., and Shagass, C., 1949, Physiologic studies of reaction to stress in anxiety and early schizophrenia, Psychosom. Med. 2:9–24.
Mansky, P. A., 1975, Opiate action, in: Opiate Receptor Mechanisms (S. H. Snyder, and S. Matthysse, eds.), Neurosci. Res. Progr. Bull. 13:13-17.
Mansky, P. A., 1976, Pentazocine (Talwin): A review to be published.
Mansky, P. A., and Altman, J., 1977, A conceptual model of drug dependence, in: Renewal in Psychiatry: A Critical Rational Perspective (T. Manschreck and A. Kleinman, eds.), pp. 139–161, Hemisphere Publishing Corp., Washington/London.
Mansky, P. A., and Jasinski, D. R., 1970, Effects of dextromethorphan in man, Pharmacologist 12:231.
Mansky, P. A., and Jasinski, D. R., 1976, Potentiation of the antinociceptive action of morphine by prior administration of dextromethorphan, in preparation.
Marquardt, W. G., Martin, W. R., and Jasinski, D. R., 1967, The use of the Polaroid CU camera in pupillography, Int. J. Addict. 2:301–304.
Martin, W. R., 1963, Analgesic and antipyretic drugs. 1. Strong analgesics, in: Physiological Pharmacology (W. S. Root and E. G. Hofman, eds.), pp. 275–312, Academic Press, New York.
Martin, W. R., 1966, Assessment of the dependence producing potentiality of narcotic analgesics, in: International Encyclopedia of Pharmacology and Therapeutics, Vol. 1 (C. Radauco-Thomas and L. Lasagna, eds.), pp. 155–180, Pergamon Press, Glasgow.
Martin, W. R., 1967a, Opioid antagonists, Pharmacol. Rev. 19:463–521.
Martin, W. R., 1967b, Clinical evaluation for narcotic dependence, in: New Concepts in Pain and Its Clinical Management (E. L. Way, ed.), pp. 121–132, F. A. Davis, Philadelphia.
Martin, W. R., 1970, Pharmacological redundancy as an adaptive mechanism in the central nervous. system, Fed. Proc. 29:13–18.
Martin, W. R., 1975, Clinical phenomenology of addiction, in: Opiate Receptor Mechanisms (S. H. Snyder and S. Matthysse, eds.), Neurosci. Res. Progr. Bull. 13:126-134.
Martin, W. R., and Eades, C. G., 1961, Demonstration of tolerance and physical dependence in the dog following short-term infusion of morphine, J. Pharmacol. Exp. Ther. 133:262–270.
Martin, W. R., and Fraser, H. F., 1961, A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in post addicts, J. Pharmacol. Exp. Ther. 133:388–399.
Martin, W. R., and Gorodetzky, C. W., 1965, Demonstration of tolerance to and physical dependence on n-allylnormorphine (nalorphine), J. Pharmacol. Exp. Ther. 150:432–442.
Martin, W. R., and Jasinski, D. R., 1969, Physiological parameters of morphine dependence in man—tolerance, early abstinence, protracted abstinence, J. Psychiat. Res. 7:9–17.
Martin, W. R., and Sloan, J. W., 1968, The pathophysiology of morphine dependence and its treatment with opioid antagonists, Pharmakopsych. Neuro-Psychopharmakol. 1:260–270.
Martin, W. R., Wikler, A., Eades, C. G., and Pescor, F. T., 1963, Tolerance to and physical dependence on morphine in rats, Psychopharmacologia 4:247–260.
Martin, W. R., Eades, C. G., Fraser, H. F., and Wikler, A., 1964, Use of hindlimb reflexes in the chronic spinal dog for comparing analgesics, J. Pharmacol. Exp. Ther. 144:8–11.
Martin, W. R., Fraser, H. F., Gorodetzky, C. W., and Rosenberg, D. E., 1965, Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2′-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, win-20, 740, ARC II-C-3), J. Pharmacol. Exp. Ther. 150:426–436.
Martin, W. R., Gorodetzky, C. W., and Mcclane, T. K., 1966, An experimental study in the treatment of narcotic addicts with cyclazocine, Clin. Pharmacol. Ther. 7:455–465.
Martin, W. R., Jasinski, D. R., Sapira, J. D., Flanary, H. G., Kelly, O. A., Thompson, A. K., and Logan, C. R., 1968, The respiratory effects of morphine during a cycle of dependence, J. Pharmacol. Exp. Ther. 162:182–189.
Martin, W. R., Jasinski, D. R., Haertzen, C. A., Kay, D. C., Jones, B. E., Mansky, P. A., and Carpenter, R. W., 1973a, Methadone—a re-evaluation, Arch. Gen. Psychiat. 28:286–295.
Martin, W. R., Jasinski, D. R., and Mansky, P. A., 1973b, Naltrexone, an antagonist for the treatment of heroin dependence, effects in man, Arch. Gen. Psychiat. 28:784–791.
Mcclane, T. K., and Martin, W. R., 1967, Effects of morphine, nalorphine, cyclazocine, and naloxone on the flexor reflex, Int. J. Neuropharmacol. 6:89–98.
Mccrea, F. D., Eadie, G. S., and Morgan, J. E., 1942, The mechanism of morphine miosis, J. Pharmacol. Exp. Ther. 74:239–246.
Mehler, W. R., Freeman, M. E., and Nauta, W. J., 1960, Ascending axonal degeneration following contralateral cordotomy, Brain 83:718–750.
Melzack, R., 1974, Psychological concepts and methods for the control of pain, in: Advances in Neurology, International Symposium on Pain, Vol. 4 (J. J. Bonica, ed.), pp. 275–288, Raven Press, New York.
Melzack, R., and Scott, T. H., 1957, The effects of early experience on the response to pain, J. Comp. Physiol. Psychol. 50:155–161.
Melzack, R., and Torgerson, W. S., 1971, On the language of pain, Anesthesiology 34:50–59.
Melzack, R., and Wall, P. D., 1965, Pain mechanisms: A new theory, Science 150:971–979.
Melzack, R., and Wall, P. D., 1968, Gate control theory of pain, in: Pain (A. Soulairac, J. Cahn, and J. Charpentier, eds.), Academic Press, New York/London.
Merskey, H., 1974, Psychological aspects of pain relief; hypnotherapy, psychotropic drugs, in: Relief of Intractable Pain (M. Swerdlow, ed.), Excerpta Medica, New York.
Monroe, J. J., Ross, W. F., and Berzins, J., 1971, The decline of the addict as “psychopath”: Implications for community care, Int. J. Addict. 6:601–608.
Mott, J., 1972, The psychological basis of drug dependence: The intellectual and personality characteristics of opiate users, Br. J. Addict. 67:89–99.
Mountcastle, V. B., 1968, Pain and temperature sensibilities, in: Medical Physiology, Vol. 2, 12th Ed. (V. B. Mountcastle, ed.), pp. 1424–1464, C. V. Mosby, St. Louis.
Mule, S. J., 1971, Physiological disposition of narcotic agonists and antagonists, in: Narcotic Drugs: Biochemical Pharmacology (D. H. Clouet, ed.), pp. 99–121, Plenum Publishing Corp., New York.
Murphree, H. B., 1962, Clinical pharmacology of potent analgesics, Clin. Pharmacol. Ther. 3:473–504.
Nauta, W. J. H., 1958, Hippocampal projections and related neural pathways to the midbrain in the cat, Brain 81:319–340.
Nauta, W. J. H., 1975, Anatomical organization of pain pathways in the central nervous system, in: Opiate Receptor Mechanisms (S. H. Snyder and S. Matthysse, eds.), Neurosci. Res. Progr. Bull. 13:84-87.
Nicolis, F. B., and Pasquariello, G., 1962, Controlled clinical trials of antitussive agents: An experimental evaluation of different methods J. Pharmacol. Exp. Ther. 136:183–189.
Noordenbos, W., 1968, Physiological correlates of clinical pain syndromes, in: Pain (A. Soulairac, J. Cahn, and J. Charpentier, eds.), Academic Press, New York/London.
Oldendorf, W. H., Hyman, S., Braun, L., and Oldendorf, S. Z., 1972, Blood-brain barrier penetration of morphine, codeine, heroin and methadone after carotid injection, Science 178:984–986.
Olds, J. S., and Olds, M. E., 1965, Drives, rewards, and the brain, in: New Directions in Psychology II, pp. 329–410, Holt, Rhinehart & Winston, New York.
Orne, M. T., 1974, Pain suppression by hypnosis and related phenomena, in: Advances in Neurology, Vol. 4, International Symposium on Pain (J. J. Bonica, ed.), 4:563-582, Raven Press, New York.
Paddock, R., Beer, G. E., Bellville, J. W., Ciliberti, B. J., Forrest, W. H., and Miller, E., 1964, Analgesic and side effects of pentazocine and morphine in a large population of postoperative patients, Clin. Pharmacol. Ther. 143:157–164.
Paddock, R., Beer, E. G., Bellville, J. W., Ciliberti, B. J., Forrest, W. H., and Miller, E. V., 1969, Analgesic and side effects of pentazocine and morphine in a large population of postoperative patients, Clin. Pharmacol. Ther. 10:355–365.
Paton, W. D. M., 1957, The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum, Br. J. Pharmacol. 12:119–127.
Pearson, J. W., Lasagna, L., and Laird, R. D., 1971, Analgesic activity of oral and intramuscular profadol, Clin. Pharmacol. Ther. 12:683–690.
Pennes, H. H., and Hoch, P. H., 1957, Psychotomimetics, clinical and theoretical considerations, Harmine, win-2292 and nalline, Am. J. Psychiat. 113:887–892.
Pihl, R. O., and Altman, J., 1971, An experimental analysis of the placebo effect, J. Clin. Pharmacol. 11:91–95.
Plum, F., and Posner, J. B., 1972, The Diagnosis of Stupor and Coma, F. A. Davis, Philadelphia.
Potter, D. R., and Payne, J. P., 1970, Newer analgesics: With special reference to pentazocine, Br. J. Anesth. 42:186–193.
Reynolds, A. K., and Randall, L. O., 1957, Morphine and Allied Drugs, Univ. of Toronto Press, Toronto.
Rioch, D. McK., 1972, Personality, Arch. Gen. Psych. 27:575–580.
Robins, L. N., and Murphy, G. E., 1967, Drug use in a normal population of young Negro men, Am. J. Public Health 57:1580–1596.
Robins, L. N., Helzer, J. E., and Davis, D. H., 1975, Narcotic use in southeast Asia and afterward, an interview of 898 Vietnam returnees, Arch. Gen. Psychiat. 32:955–961.
Sapira, J. D., 1968, The narcotic addict as a medical patient, Am. J. Med. 45:555–588.
Saum, W. R., and De Groat, W. C, 1972, Parasympathetic ganglia: Activation of an adrenergic inhibitory mechanism by cholinomimetic agents, Science 175:659–661.
Scarfani, J. T., and Clouet, D. H., 1971, Biotransformations, in: Narcotic Drugs: Biochemical Pharmacology (D. H. Clouet, ed.), pp. 137–158, Plenum Publishing Corp., New York.
Sceleth, C. E., and Kuh, S., 1924, Drug addiction, JAMA 82:679–682.
Schmidt, R. F., 1972, The gate control theory of pain: An unlikely hypothesis, in: Pain (R. Jansen, W. D. Keidel, A. Herz, and C. Stichele, eds.) (English Ed.: J. P. Payne and R. A. P. Burt, eds.), pp. 124–127, Williams & Wilkins, Baltimore.
Seed, J. C, Wallenstein, S. L., Houde, R. W., and Bellville, J. W., 1958, A comparison of the analgesic and respiratory effects of dihydrocodeine and morphine in man, Arch. Int. Pharmacodyn. Ther. 116:293–339.
Sevelius, H., Mccoy, J. F., and Colmore, J. P., 1971, Dose response to codeine in patients with chronic cough. Clin. Pharmacol. Ther. 12:449–455.
Shor, R. E., 1962, Physiological effects of painful stimulation during hypnotic analgesia under conditions designed to minimize anxiety, Int. J. Clin. Exp. Hypn. 10:183–202.
Smith, G. M., and Beecher, H. K., 1959, Measurement of “mental clouding” and other subjective effects of morphine, J. Pharmacol. 126:50–62.
Smith, G. M., and Beecher, H. K., 1969, Experimental production of pain in man: Sensitivity of a new method to 600 mg. of aspirin, Clin. Pharmacol. Ther. 10:213–216.
Smith, G. M., Egbert, L. D., Markowitz, R. A., Mosteller, F., and Beecher, H. K., 1966, An experimental pain method sensitive to morphine in man: The submaximum effort tourniquet technique, J. Pharmacol. Exp. Ther. 154:324–332.
Smith, G. M., Lowenstein, E., Hubbard, J. H., and Beecher, H. K., 1968, Experimental pain produced by the submaximum effort tourniquet technique: Further evidence of validity, J. Pharmacol. Exp. Ther. 163: 468–474.
Sternbach, R. A., 1968, Hypnotic and placebo effects, in: Pain, A Psychophysiological Analysis, pp. 133–146, Academic, Press, New York/London.
Sternbach, R. A., 1974a, Pain and depression, in: Somatic Manifestations of Depressive Disorders (A. Kiev, ed.), Excerpta Medica, Princeton.
Sternbach, R. A., 1974b, Varieties of pain games, in: Advances in Neurology, Vol. 4, International Symposium on Pain (J. J. Bonica, ed.), pp. 423–430, Raven Press, New York.
Sunshine, A., Laska, B., and Slafta, J., 1970, A comparison of the analgesic effects of profadol (Parke-Davis CI-572) and morphine, Report of thirty-second scientific meeting of The Committee on Problems of Drug Dependence, NAS-NRC, pp. 6899-6901.
Theobald, W., Wilhelmi, G., and Krupp, P., 1968, Analgesic and anticonvalesant activity of derivatives of dibenz (b,f) azepine, in: Pain (A. Soulairac, J. Cahn, and J. Charpentier, eds.), pp. 239–249, Academic Press, New York /London.
Thomas, M., Malmcrona, R., Fillmore, S., and Shillingford, J., 1965, Haemodynamic effects of morphine in patients with acute myocardial infarction, Br. Heart f. 27:863–875.
Valliant, G. E., 1966, A twelve-year follow-up of New York narcotic addicts: I. The relationship of treatment to outcome, Am. J. Psychiat. 122:727–737.
Vasko, J. S., Henney, R. P., Oldham, H. N., Brawley, R. K., and Morrow, A. G., 1966, Mechanism of action of morphine in the treatment of experimental pulmonary edema, Am. f. Cardiol. 18:876–883.
Von Felsinger, J. M., Lasagna, L., and Beecher, H. K., 1955, Drug-induced mood changes in man. 2. Personality and reactions to drugs, JAMA 157:1113–1119.
Wallenstein, S. L., and Houde, R. W., 1975, The clinical evaluation of analgesic effectiveness, in: Methods in Narcotics Research (S. Ehrenpreis and A. Neidle, eds.), pp. 127–145, Marcel Dekker, New York.
Wallenstein, S. L., Houde, R. W., and Beaver, W. T., 1967, Analgesic studies of orally and parenterally administered morphine and codeine in patients with cancer, Fed. Proc. 26:742.
Wang, S. C., and Galviano, V. V., 1954, Locus of emetic action of morphine and hydergine in dogs, J. Pharmacol. Exp. Ther. 111:329–334.
Way, E. L., and Adler, T. K., 1960, The pharmacologic implications of the fate of morphine and its surrogates, Pharmacol. Rev. 12:383–446.
Way, E. L., and Adler, T. K., 1961, The biological disposition of morphine and its surrogates— 1, Bull. WHO 25:227–262.
Way, E. L., and Adler, T. K., 1962, The biological disposition of morphine and its surrogates—4, Bull. WHO 27:359–394.
Whitehead, C.C., 1974, Methadone psuedowithdrawal syndrome: Paradigm for a psychopharmacological model of opiate addiction, Psychosom. Med. 36:189–198.
WHO Expert Committee on Drug Dependence, Sixteenth Report (1969), WHO Techn. Rep., Ser. 407.
Wikler, A., 1944, Studies on the action of morphine on the central nervous system of the cat, J. Pharmacol Exp. Ther. 80:176–197.
Wikler, A., 1948, Recent progress in research on the neurophysiological basis of morphine addiction, Am. J. Psychiat. 105:329–338.
Wikler, A., 1952, A psychodynamic study of a patient during experimental self-regulated re-addiction to morphine, Psychiat. Quart. 26:270–293.
Wikler, A., 1953, Opiate Addiction, Charles C Thomas, Springfield, Ill.
Wikler, A., 1958, Mechanisms of Action of Opiates and Opiate Antagonists: A Review of Their Mechanisms of Action in Relation to Clinical Problems, Public Health Monograph No. 52, U.S. Government Printing Office, Washington, D.C.
Wikler, A., 1966, Designated discussion, in: Pain (R. S. Knighton and P. R. Dumke, eds.), Little, Brown, Boston.
Wikler, A., 1968, Interaction of physical dependence and classical and operant conditioning in the genesis of relapse, in: The Addictive States (A. Wilder, ed.), pp. 280–287, Williams & Wilkins, Baltimore.
Wikler, A., 1973, Dynamics of drug dependence, implications of a conditioning theory for research and treatment, Arch. Gen. Psychiat. 28:611–616.
Wikler, A., and Carter, R. L., 1953, Effects of single doses of n-allylnormorphine on hindlimb reflexes of chronic spinal dogs during a cycle of morphine addiction, J. Pharmacol, Exp. Ther. 109:92–101.
Wikler, A., and Frank, K., 1948, Hindlimb reflexes of chronic spinal dogs during cycles of addiction to morphine and methadone, J. Pharmacol. Exp. Ther. 94:382–400.
Wikler, A., and Pescor, F. T., 1967, Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and “relapse” in morphineaddicted rats, Psychopharmacologia 10:255–284.
Wikler, A., Pescor, M. J., Kalbaugh, F. P., and Angelluci, R. J., 1952, Effects of frontal lobotomy on the morphine abstinence syndrome in man, AMA Arch. Neurol. Psychiatry 67:510–521.
Wikler, A., Fraser, H. F., and Isbell, H., 1953, N-allylnormorphine: Effects of single doses and precipitation of acute “abstinence syndromes” during addiction to morphine, methadone or heroin in man (post-addicts), J. Pharmacol. Exp. Ther. 109:8–20.
Winokur, G., Clayton, P. J., and Reich, T., 1969, Manic Depressive Illness, C. V. Mosby, St. Louis.
Winokur, G., Reich, T., Rimmer, J., and Pitts, F. N., 1970, Alcoholism. III. Diagnosis and familial psychiatric illness in 259 alcoholic probands, Arch. Gen. Psychiat. 23:104–111.
Wolf, H. G., and Hardy, J. D., 1947, On the nature of pain, Physiol. Rev. 27:167–199.
Wolf, H. G., Hardy, J. D., and Goodell, H., 1940, Studies on pain, measurement of the effect of morphine, codeine, and other opiates on pain threshold and an analysis of their relation to the pain experience, J. Clin. Invest. 9:659–680.
Woodforde, J. M., and Merskey, H., 1972, Personality traits of patients with chronic pain, J. Psychosom. Res. 16:167–172.
Woodruff, R. A., Goodwin, D. W., and Guze, S. B., 1974, Psychiatric Diagnosis, Oxford Univ. Press, New York.
Woods, L. A., 1954, Distribution and fate of morphine in non-tolerant and tolerant dogs and rats, J. Pharmacol. Exp. Ther. 112:158.
Yerkes, R. M., and Dodson, J. D., 1908, The relationship of strength of stimulus to rapidity of habit formation, J. Comp. Neurol Psychol. 18:459–482.
Zborowski, M., 1952, Cultural components in responses to pain, J. Social Issues 8:16–30.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Mansky, P.A. (1978). Opiates: Human Psychopharmacology. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds) Drugs of Abuse. Handbook of Psychopharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3186-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3186-5_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3188-9
Online ISBN: 978-1-4684-3186-5
eBook Packages: Springer Book Archive